Abstract
Single 500-mg intramuscular doses of imipenem-cilastatin cured 116 (95%) of 122 men and 9 of 9 women with uncomplicated gonorrhea due to beta-lactamase-negative Neisseria gonorrhoeae. Most co-existing Chlamydia trachomatis infections persisted. Imipenem-cilastatin is effective for uncomplicated gonorrhea in men but has no advantages over other available regimens.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / therapeutic use*
-
Chlamydia Infections / complications
-
Chlamydia Infections / drug therapy
-
Chlamydia trachomatis
-
Cilastatin
-
Cilastatin, Imipenem Drug Combination
-
Cyclopropanes / administration & dosage
-
Cyclopropanes / therapeutic use
-
Drug Combinations / administration & dosage
-
Drug Combinations / therapeutic use
-
Female
-
Gonorrhea / complications
-
Gonorrhea / drug therapy*
-
Humans
-
Imipenem
-
Injections, Intramuscular
-
Male
-
Thienamycins / administration & dosage
-
Thienamycins / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Cyclopropanes
-
Drug Combinations
-
Thienamycins
-
Cilastatin
-
Imipenem
-
Cilastatin, Imipenem Drug Combination